VISCODERM references stocked by ALLPARA for professional use, sourced direct and certified on every shipment.
Viscoderm 0.8
Viscoderm 0.8 is an injectable biorevitalisation gel implant by Viscoderm, formulated with native hyaluronic acid at 8 mg/ml whose molecular weight is similar to endogenous hyaluronic acid. It is commonly used by clinics, dermatologists and aesthetic practitioners on especially thin and delicate skin and in preventive biorevitalisation protocols. The hyaluronic acid is obtained by biofermentation from natural raw materials without chemical modification, and the product is intended for professional use by qualified practitioners.
Key Benefits of Viscoderm 0.8
- Native hyaluronic acid at 8 mg/ml, with a molecular weight similar to endogenous hyaluronic acid
- Formulated for especially thin and delicate skin areas
- Suitable for preventive biorevitalisation protocols
- Hyaluronic acid obtained by biofermentation from natural raw materials, without chemical modification
- Supports high biocompatibility and good tolerability
- Improves hydration, skin quality and elasticity
- Suitable for different professional injection techniques
- Sterile and apyrogenic syringe content
Indications and Professional Use
Main indications
- Early and moderate age-related skin changes
- Genetically dry skin prone to fine lines
- Skin affected by frequent or prolonged sunbed exposure
- Smoker's skin
- Stressed skin
- Skin requiring improved adaptive capacity during acne, pigmentation or aggressive aesthetic treatment courses
- Post-acne skin rehabilitation
- Atrophic scars
- Stretch marks
- Preventive biorevitalisation procedures
- Thin and delicate skin areas
Professional use
Viscoderm 0.8 is an injectable gel implant supplied for professional use only and must be administered by qualified medical practitioners. The syringe content is sterile and apyrogenic, the product is single-use, and aseptic technique applies throughout; any unused content is discarded. The article notes the product suits different professional injection techniques, and the treating practitioner determines the technique, injection plane, dose per point and session interval for each indication and treated area. Treatment is contraindicated in hypersensitivity to any component of the preparation, pregnancy and breastfeeding, acute infectious or inflammatory disease, autoimmune disease, a tendency to hypertrophic or keloid scar formation, blood coagulation disorders, and in patients using anticoagulant or antiplatelet agents.
Treatment areas
- Face
- Body
- Thin and delicate skin areas
Patient profile
Viscoderm 0.8 is intended for adult patients with early or moderate age-related skin changes, dry or stressed skin, or especially thin and delicate skin, and for patients undergoing preventive biorevitalisation. Suitability is determined by the treating practitioner following clinical assessment. It must not be used in patients with hypersensitivity to any component of the preparation, in pregnancy or breastfeeding, in acute infectious or inflammatory disease, in autoimmune disease, in patients prone to hypertrophic or keloid scarring, in patients with blood coagulation disorders, or in patients taking anticoagulants or antiplatelet agents.
How Viscoderm 0.8 Works
Viscoderm 0.8 works through native hyaluronic acid at 8 mg/ml, obtained by biofermentation from natural raw materials and supplied without chemical modification, so its molecular weight is similar to the hyaluronic acid already present in the skin. Injected intradermally, it restores the dermal hyaluronic acid pool, which improves hydration, skin quality and elasticity. The low concentration in the range makes it suitable for especially thin and delicate skin and for preventive protocols, where a lighter biorevitalising effect is the treatment goal.
Why Order From Allpara
Allpara offers genuine, verified VISCODERM products from vetted suppliers, with full batch-traceability and expert support. We serve clinics and aesthetic professionals with CE-certified products, fast EU-wide delivery from our EU warehouse, and competitive trade pricing. Our focus is your patients' safety, satisfaction and results - with dedicated after-sales support for your peace of mind.
Frequently Asked Questions
How does Viscoderm 0.8 differ from Viscoderm 1.6 and 2.0?
The three products differ in hyaluronic acid concentration. Viscoderm 0.8 contains native hyaluronic acid at 8 mg/ml and is the lightest of the range, formulated for especially thin and delicate skin and for preventive protocols. Viscoderm 1.6 contains 24 mg per 1.5 ml syringe and Viscoderm 2.0 contains native hyaluronic acid at 2.0%.
Which areas can Viscoderm 0.8 be used on?
Viscoderm 0.8 is used on the face and body, and is formulated in particular for areas where the skin is especially thin and delicate.
Which needles are supplied with Viscoderm 0.8?
Each Viscoderm 0.8 pack contains 3 syringes of 1 ml and 6 needles of 30G x 12 mm.
Is the hyaluronic acid in Viscoderm 0.8 chemically modified?
No. The hyaluronic acid in Viscoderm 0.8 is obtained by biofermentation from natural raw materials and is produced without chemical modification, which supports its biocompatibility and tolerability.
Who should not be treated with Viscoderm 0.8?
Viscoderm 0.8 is contraindicated in hypersensitivity to any component of the preparation, pregnancy and breastfeeding, acute infectious or inflammatory disease, autoimmune disease, a tendency to hypertrophic or keloid scarring, blood coagulation disorders, and use of anticoagulant or antiplatelet medication.
More from IBSA
ALIAXIN references stocked by ALLPARA for professional use, sourced direct and certified on every shipment.
ALIAXIN Products
View all 6PROFHILO references stocked by ALLPARA for professional use, sourced direct and certified on every shipment.
PROFHILO Products
View all 8SINOVIAL references stocked by ALLPARA for professional use, sourced direct and certified on every shipment.
SINOVIAL Products
View all 4Clinic alternatives
Pick up where you left off
Viscoderm 0.8
Viscoderm 0.8 is an injectable biorevitalisation gel implant by Viscoderm, formulated with native hyaluronic acid at 8 mg/ml whose molecular weight is similar to endogenous hyaluronic acid. It is commonly used by clinics, dermatologists and aesthetic practitioners on especially thin and delicate skin and in preventive biorevitalisation protocols. The hyaluronic acid is obtained by biofermentation from natural raw materials without chemical modification, and the product is intended for professional use by qualified practitioners.
Key Benefits of Viscoderm 0.8
- Native hyaluronic acid at 8 mg/ml, with a molecular weight similar to endogenous hyaluronic acid
- Formulated for especially thin and delicate skin areas
- Suitable for preventive biorevitalisation protocols
- Hyaluronic acid obtained by biofermentation from natural raw materials, without chemical modification
- Supports high biocompatibility and good tolerability
- Improves hydration, skin quality and elasticity
- Suitable for different professional injection techniques
- Sterile and apyrogenic syringe content
Indications and Professional Use
Main indications
- Early and moderate age-related skin changes
- Genetically dry skin prone to fine lines
- Skin affected by frequent or prolonged sunbed exposure
- Smoker's skin
- Stressed skin
- Skin requiring improved adaptive capacity during acne, pigmentation or aggressive aesthetic treatment courses
- Post-acne skin rehabilitation
- Atrophic scars
- Stretch marks
- Preventive biorevitalisation procedures
- Thin and delicate skin areas
Professional use
Viscoderm 0.8 is an injectable gel implant supplied for professional use only and must be administered by qualified medical practitioners. The syringe content is sterile and apyrogenic, the product is single-use, and aseptic technique applies throughout; any unused content is discarded. The article notes the product suits different professional injection techniques, and the treating practitioner determines the technique, injection plane, dose per point and session interval for each indication and treated area. Treatment is contraindicated in hypersensitivity to any component of the preparation, pregnancy and breastfeeding, acute infectious or inflammatory disease, autoimmune disease, a tendency to hypertrophic or keloid scar formation, blood coagulation disorders, and in patients using anticoagulant or antiplatelet agents.
Treatment areas
- Face
- Body
- Thin and delicate skin areas
Patient profile
Viscoderm 0.8 is intended for adult patients with early or moderate age-related skin changes, dry or stressed skin, or especially thin and delicate skin, and for patients undergoing preventive biorevitalisation. Suitability is determined by the treating practitioner following clinical assessment. It must not be used in patients with hypersensitivity to any component of the preparation, in pregnancy or breastfeeding, in acute infectious or inflammatory disease, in autoimmune disease, in patients prone to hypertrophic or keloid scarring, in patients with blood coagulation disorders, or in patients taking anticoagulants or antiplatelet agents.
How Viscoderm 0.8 Works
Viscoderm 0.8 works through native hyaluronic acid at 8 mg/ml, obtained by biofermentation from natural raw materials and supplied without chemical modification, so its molecular weight is similar to the hyaluronic acid already present in the skin. Injected intradermally, it restores the dermal hyaluronic acid pool, which improves hydration, skin quality and elasticity. The low concentration in the range makes it suitable for especially thin and delicate skin and for preventive protocols, where a lighter biorevitalising effect is the treatment goal.
Why Order From Allpara
Allpara offers genuine, verified VISCODERM products with full batch-traceability, CE-certified stock, fast EU-wide delivery and expert after-sales support.
Frequently Asked Questions
How does Viscoderm 0.8 differ from Viscoderm 1.6 and 2.0?
The three products differ in hyaluronic acid concentration. Viscoderm 0.8 contains native hyaluronic acid at 8 mg/ml and is the lightest of the range, formulated for especially thin and delicate skin and for preventive protocols. Viscoderm 1.6 contains 24 mg per 1.5 ml syringe and Viscoderm 2.0 contains native hyaluronic acid at 2.0%.
Which areas can Viscoderm 0.8 be used on?
Viscoderm 0.8 is used on the face and body, and is formulated in particular for areas where the skin is especially thin and delicate.
Which needles are supplied with Viscoderm 0.8?
Each Viscoderm 0.8 pack contains 3 syringes of 1 ml and 6 needles of 30G x 12 mm.
Is the hyaluronic acid in Viscoderm 0.8 chemically modified?
No. The hyaluronic acid in Viscoderm 0.8 is obtained by biofermentation from natural raw materials and is produced without chemical modification, which supports its biocompatibility and tolerability.
Who should not be treated with Viscoderm 0.8?
Viscoderm 0.8 is contraindicated in hypersensitivity to any component of the preparation, pregnancy and breastfeeding, acute infectious or inflammatory disease, autoimmune disease, a tendency to hypertrophic or keloid scarring, blood coagulation disorders, and use of anticoagulant or antiplatelet medication.